Augmentation of bovine leukemia virus (BLV)-specific lymphocyte proliferation responses in ruminants by inoculation with BLV env-recombinant vaccinia virus: their role in the suppression of BLV replication
- PMID: 1337572
- DOI: 10.1111/j.1348-0421.1992.tb02133.x
Augmentation of bovine leukemia virus (BLV)-specific lymphocyte proliferation responses in ruminants by inoculation with BLV env-recombinant vaccinia virus: their role in the suppression of BLV replication
Abstract
Lymphocyte proliferation responses were investigated in sheep and cattle, in which the replication of bovine leukemia virus (BLV) had been known to be suppressed by inoculation with recombinant vaccinia virus (rVV) expressing BLV envelope glycoprotein (gp60). Enhanced lymphocyte proliferation responses were observed in animals inoculated with rVV, regardless of whether they were naive or BLV carriers. These responses were roughly inversely correlated to the growth of BLV in the peripheral blood leukocytes. In contrast, there was no apparent correlation between humoral immune response and BLV growth. Based on these results, it was suggested that rVV rendered its suppressive effect of BLV replication primarily via augmentation of cell-mediated immunity.
Similar articles
-
Protective immunity against bovine leukaemia virus (BLV) induced in carrier sheep by inoculation with a vaccinia virus-BLV env recombinant: association with cell-mediated immunity.J Gen Virol. 1991 Aug;72 ( Pt 8):1887-92. doi: 10.1099/0022-1317-72-8-1887. J Gen Virol. 1991. PMID: 1651982
-
Role of cell-mediated immunity in bovine leukemia virus (BLV) infection in ruminants: its implication for the vaccination strategy against retroviruses.Ther Immunol. 1994 Oct;1(5):297-301. Ther Immunol. 1994. PMID: 7584504 Review.
-
Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.J Virol. 1993 Apr;67(4):1803-10. doi: 10.1128/JVI.67.4.1803-1810.1993. J Virol. 1993. PMID: 7680387 Free PMC article.
-
Involvement of CD8+ T cells in delayed-type hypersensitivity responses against bovine leukemia virus (BLV) induced in sheep vaccinated with recombinant vaccinia virus expressing BLV envelope glycoprotein.Vet Pathol. 1993 Mar;30(2):104-10. doi: 10.1177/030098589303000202. Vet Pathol. 1993. PMID: 8470333
-
Recombinant viral vaccines for enzootic bovine leucosis.Immunol Cell Biol. 1993 Oct;71 ( Pt 5):399-404. doi: 10.1038/icb.1993.46. Immunol Cell Biol. 1993. PMID: 8270269 Review.
Cited by
-
Preventive and therapeutic strategies for bovine leukemia virus: lessons for HTLV.Viruses. 2011 Jul;3(7):1210-48. doi: 10.3390/v3071210. Epub 2011 Jul 19. Viruses. 2011. PMID: 21994777 Free PMC article. Review.
-
Progression to persistent lymphocytosis and tumor development in bovine leukemia virus (BLV)-infected cattle correlates with impaired proliferation of CD4+ T cells in response to gag- and env-encoded BLV proteins.J Virol. 1996 Nov;70(11):7584-93. doi: 10.1128/JVI.70.11.7584-7593.1996. J Virol. 1996. PMID: 8892878 Free PMC article.
-
BLV: lessons on vaccine development.Retrovirology. 2019 Oct 7;16(1):26. doi: 10.1186/s12977-019-0488-8. Retrovirology. 2019. PMID: 31590667 Free PMC article. Review.
-
Vaccination against δ-retroviruses: the bovine leukemia virus paradigm.Viruses. 2014 Jun 20;6(6):2416-27. doi: 10.3390/v6062416. Viruses. 2014. PMID: 24956179 Free PMC article. Review.
-
Association of Bovine Leukemia Virus-Induced Lymphoma with BoLA-DRB3 Polymorphisms at DNA, Amino Acid, and Binding Pocket Property Levels.Pathogens. 2021 Apr 6;10(4):437. doi: 10.3390/pathogens10040437. Pathogens. 2021. PMID: 33917549 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources